Home Ingredients Potassium Bicarbonate
Bone HealthMetabolic HealthLongevity

Potassium Bicarbonate

Evidence Level
Moderate
2 Clinical Trials
5 Documented Benefits
3/5 Evidence Score

Potassium bicarbonate (KHCO3) is an alkalizing potassium salt studied mainly for bone and acid-base health rather than simple potassium repletion. Providing about 39% elemental potassium, it delivers potassium together with bicarbonate, a base that neutralizes the modest acid load generated by typical Western diets and that tends to increase with age. In older adults, supplemental potassium bicarbonate has been shown to lower urinary calcium loss and reduce a marker of bone breakdown. However, these are surrogate biochemical endpoints, not proven reductions in fractures, and at least one trial indicates the bicarbonate, not the potassium, is responsible for the bone effect.

Studied Dose Bone-health trials used about 1 to 1.5 mmol/kg per day (roughly 60-90 mEq potassium daily) for up to 3 months in adults aged 50 and older.
Active Compound Potassium bicarbonate (KHCO3), an alkaline potassium salt providing roughly 39% elemental potassium plus bicarbonate as an alkalizing buffer.

Benefits

Supports Bone Mineral Conservation

By providing alkali that buffers dietary acid load, potassium bicarbonate has been shown to reduce urinary calcium excretion in older adults, which may help the body conserve calcium that would otherwise be lost in the urine.

Supported by Trial 2, Trial 1

May Lower Bone Breakdown Markers

Supplementation has been associated with reductions in a urinary marker of bone resorption, suggesting it may support a more favorable balance of bone turnover, though effects on actual fracture risk have not been demonstrated.

Supported by Trial 1, Trial 2

Counters Dietary Acid Load

Typical modern diets generate a low-grade metabolic acid load that rises with age; the bicarbonate component helps neutralize this load and supports normal acid-base balance, the proposed basis for its skeletal effects.

Supported by Trial 2, Trial 1

Provides Alkalizing Potassium

Unlike neutral potassium salts, potassium bicarbonate supplies potassium alongside base, helping maintain potassium status while also contributing to the body's buffering capacity.

Supported by Trial 2, Trial 1

Supports Healthy Aging Of Bone

Because age-related acidosis is thought to contribute to gradual calcium loss, alkalizing supplementation is of interest for supporting bone health during aging, recognizing the evidence rests on biochemical rather than fracture outcomes.

Supported by Trial 2

Mechanism of action

1

Acid-Base Buffering

The bicarbonate anion neutralizes hydrogen ions from dietary acid precursors, raising systemic buffering capacity and reducing the chronic low-grade metabolic acidosis associated with high-protein, low-vegetable diets and aging.

2

Reduced Calcium Wasting

Lowering the acid load decreases the need to mobilize alkaline bone salts and reduces renal calcium excretion, helping retain calcium in the body rather than losing it through the urine.

3

Bone Turnover Modulation

Acid loading stimulates osteoclastic bone resorption while suppressing osteoblastic activity; supplying base is proposed to shift this balance, reflected in reduced bone-resorption markers in supplementation trials.

4

Bicarbonate Is The Active Component

Controlled comparisons indicate the alkalizing bicarbonate, rather than the potassium ion itself, drives the reductions in calcium excretion and bone resorption, distinguishing this salt from neutral potassium forms.

Clinical trials

1
Potassium bicarbonate dose-finding trial on bone turnover

Double-blind, placebo-controlled randomized dose-finding trial of placebo, 1 mmol/kg, or 1.5 mmol/kg KHCO3 daily for 3 months

244 men and women aged 50 and older

The lower dose reduced the bone-resorption marker urinary NTX by about 19% and lowered a bone-formation marker, and both doses significantly reduced urinary calcium versus placebo, indicating a favorable shift in bone biochemistry over 3 months.

2
Bicarbonate versus potassium on calcium and bone resorption

Randomized controlled trial designed to separate the effects of the bicarbonate anion from the potassium cation on bone-related outcomes in older adults

Healthy older men and women

Bicarbonate, but not potassium, lowered urinary calcium excretion and bone resorption, indicating that the alkalizing effect rather than the potassium itself is responsible for the skeletal benefit observed with potassium bicarbonate.

Side effects and drug interactions

Common Potential side effects

Gastrointestinal upset, gas, or bloating can occur, particularly at higher daily doses.
Excess intake can raise blood potassium, posing a risk of hyperkalemia in susceptible people.
The alkalizing effect can shift systemic acid-base balance if taken in large amounts.
People with kidney impairment are at increased risk of potassium accumulation.
Fracture-prevention benefit is unproven, so it should not replace established bone-health measures.

Important Drug interactions

ACE inhibitors raise serum potassium and combined use increases the risk of hyperkalemia.
Angiotensin receptor blockers (ARBs) likewise elevate potassium and warrant caution.
Potassium-sparing diuretics such as spironolactone can cause dangerous hyperkalemia with added potassium salts.
People with chronic kidney disease should use potassium bicarbonate only under medical supervision due to hyperkalemia risk.

More Bone Health Ingredients

Bone Health
Calcium
Calcium is the most abundant mineral in the body — about 99% stored in bones and teeth, wi…
Bone Health
Vitamin D
Vitamin D is a fat-soluble vitamin and steroid hormone precursor essential for calcium abs…
Muscle & Recovery
Magnesium
Magnesium is the fourth most abundant mineral in the body and a cofactor for over 300 enzy…
Bone Health
Copper
Copper is an essential trace mineral and cofactor for over 30 enzymatic reactions, includi…

Frequently asked questions about Potassium Bicarbonate

What is the recommended dosage of Potassium Bicarbonate?

The clinically studied dose for Potassium Bicarbonate is Bone-health trials used about 1 to 1.5 mmol/kg per day (roughly 60-90 mEq potassium daily) for up to 3 months in adults aged 50 and older.. Always follow product labeling and consult a healthcare provider for personalized dosing recommendations.

What is Potassium Bicarbonate used for?

Potassium Bicarbonate is studied for supports bone mineral conservation, may lower bone breakdown markers, counters dietary acid load. By providing alkali that buffers dietary acid load, potassium bicarbonate has been shown to reduce urinary calcium excretion in older adults, which may help the body conserve calcium that would otherwise be lost in the urine.

Are there side effects from taking Potassium Bicarbonate?

Reported potential side effects may include: Gastrointestinal upset, gas, or bloating can occur, particularly at higher daily doses. Excess intake can raise blood potassium, posing a risk of hyperkalemia in susceptible people. Always consult a healthcare provider before starting any new supplement, especially if you have underlying conditions or take medications.

Does Potassium Bicarbonate interact with medications?

Known drug interactions may include: ACE inhibitors raise serum potassium and combined use increases the risk of hyperkalemia. Angiotensin receptor blockers (ARBs) likewise elevate potassium and warrant caution. Consult a pharmacist or healthcare provider if you take prescription medications.

Is Potassium Bicarbonate good for bone health?

Yes, Potassium Bicarbonate is researched for Bone Health support. By providing alkali that buffers dietary acid load, potassium bicarbonate has been shown to reduce urinary calcium excretion in older adults, which may help the body conserve calcium that would otherwise be lost in the urine.

References(2 citations)

Evidence ratings on NutraSmarts are based on the totality of human clinical research, with emphasis on randomized controlled trials, meta-analyses, and systematic reviews. The references below directly support claims made throughout this page.

  1. Dawson-Hughes B, Harris SS, Palermo NJ, Gilhooly CH, Shea MK, Fielding RA, Ceglia L Potassium Bicarbonate Supplementation Lowers Bone Turnover and Calcium Excretion in Older Men and Women: A Randomized Dose-Finding Trial Journal of Bone and Mineral Research. 2015;J Bone Miner Res. 2015 Nov;30(11):2103-11.PubMedUsed to support: Randomized dose-finding trial (n=244, age 50+) showing potassium bicarbonate lowered the bone-resorption marker urinary NTX (~19% at the lower dose) and reduced urinary calcium versus placebo over 3 months; surrogate bone-turnover endpoints, not fracture outcomes.
  2. Dawson-Hughes B, Harris SS, Palermo NJ, Castaneda-Sceppa C, Rasmussen HM, Dallal GE Treatment with potassium bicarbonate lowers calcium excretion and bone resorption in older men and women Journal of Clinical Endocrinology & Metabolism. 2009;J Clin Endocrinol Metab. 2009 Jan;94(1):96-102.PubMedUsed to support: Earlier randomized trial showing that the bicarbonate anion, but NOT potassium, lowered urinary calcium excretion and bone resorption in older adults, indicating the alkalizing effect rather than the potassium drives the skeletal benefit.